Lazard Asset Management »

Bridgebio Pharma shares owned by Lazard Asset Management

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Lazard Asset Management from 13F filings

Historical chart of Lazard Asset Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Lazard Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $4.7M 5.5M 0.86
2024-09-30 $4.6M 5.5M 0.84

More positions owned by Lazard Asset Management

Microsoft Corp Common Stock (MSFT)
Amazon.com Common Stock (AMZN)
Apple Common Stock (AAPL)
Alphabet Inc A Common Stock (GOOGL)
Visa Common Stock (V)
Intercontinen Common Stock (ICE)
Bank Of America Common Stock (BAC)
Norfolk Souther Common Stock (NSC)
Broadcom Common Stock (AVGO)
Unitedhealth Gr Common Stock (UNH)
Exelon Corp Common Stock (EXC)
Accenture Common Stock (ACN)
Taiwan Semi- CommonStock ADR (TSM)
Aon Plc/ireland Common Stock (AON)
Thermo Fisher Common Stock (TMO)

View all positions for Lazard Asset Management

Top funds holding Bridgebio Pharma

Linden Advisors
Ing Investment Management
Braidwell
D. E. Shaw & Co
Weiss Asset Management LP[1
Ameriprise Financial
Aristeia Capital
Davidson Kempner Capital Management
MacKay Shields
FMR
Laurion Capital Management
State Street Corporation
Wells Fargo & Company
Bank of America Corporation
Sona Asset Management

View all funds holding Bridgebio Pharma